Credit Suisse vice chair faces re-election opposition -FT



ZURICH, Feb 9 (Reuters) - Credit Suisse CSGN.S Vice Chair Severin Schwan will face opposition from some major shareholders if he stands for re-election to the board of the embattled Swiss bank in April, the Financial Times reported on Wednesday.

The FT said the investors were concerned about Schwan leading pharmaceuticals and diagnostics group Roche ROG.S , where he is chief executive, while at the same time acting as the vice-chair of Switzerland's second largest bank.

Some investors, who were among the 10 biggest shareholders in Credit Suisse, said they will try to block any move to extend the tenure Schwan, who has been vice chair at the bank since April 2017, the FT said, without naming them.

Both Credit Suisse, which is due to report its results on Thursday, and Roche declined to comment on the report.

Over the course of Schwan's time at Credit Suisse its share price has slumped by 64% after the bank became embroiled in a string of scandals and losses.

Schwan, who joined the board of Credit Suisse in 2014, is also the lead independent director and had intended to leave before the bank's annual meeting in April, the newspaper said, citing three people familiar with the matter.

But he has been asked to stay by other board members to maintain stability under new chair, Axel Lehmann, who took charge last month after the abrupt exit of Antonio Horta-Osorio over breaches of coronavirus quarantine rules.

"If he's up for election there will be a fight," one top 10 shareholder was quoted as saying by the newspaper.

"His role as Roche CEO does not benefit Credit Suisse . . . he should (leave Credit Suisse) and go on to another board," another top 10 shareholder was quoted by the FT as saying.

Schwan told Swiss newspaper Tages-Anzeiger in January that he was undecided whether to stand for re-election at Credit Suisse's annual shareholder meeting on April 29.

"The task now is to stabilise the bank, and I am happy to support the new chairman in this," he added.
Reporting by John Revill; Editing by Michael Shields and Alexander Smith

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明